INTEGRA LIFESCIENCES HOLDINGS CORPORATION

Consensus Integra LifeSciences Holdings Corporation

Stocks

IART

US4579852082

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 21:00:00 15/10/2026 BST			5-day change	1st Jan Change
13.53 ^USD	+2.69%		+0.89%	+8.94%

10-14	Truist Securities Adjusts Integra LifeSciences Price Target to $15 From $19	MT
10-12	Integra LifeSciences Prices $450 Million in Senior Secured Notes Due 2033	MT

Evolution of the Average Target: Integra LifeSciences Holdings Corporation

Evolution of the Target Price: Integra LifeSciences Holdings Corporation

Changes in Analyst Recommendations: Integra LifeSciences Holdings Corporation

e7d98f69464.yn_axW__BSXRW7cC6iFhsCfAWnmAaD08spTzRCHjDMM.hwXpriCPZlLmCPxgmWcy6Un4C07YOgVp6rm8AFG0SveZL4ygCNJveqgx8g~5d59aa7e636181973dbded258eea7790

Analysts' recommendations: Integra LifeSciences Holdings Corporation

10-14	Truist Securities Adjusts Integra LifeSciences Price Target to $15 From $19	MT
07-30	BMO Cuts Price Target on Integra LifeSciences Holdings to $18 From $19, Keeps Market Perform Rating	MT
07-28	UBS Initiates Coverage on Integra LifeSciences With Neutral Rating, $19 Price Target	MT
07-16	Truist Adjusts Price Target on Integra LifeSciences Holdings to $19 From $14, Maintains Hold Rating	MT
07-09	BMO Capital Initiates Integra LifeSciences at Market Perform With $19 Price Target	MT
06-18	Integra LifeSciences Shares Rise After Upgrade From Argus Research	MT
06-18	Argus Research Upgrades Integra LifeSciences to Buy From Hold, $25 Price Target	MT
05-28	Citigroup Upgrades Integra LifeSciences to Neutral From Sell, Adjusts Price Target to $16 From $11	MT
05-06	Truist Adjusts Price Target on Integra LifeSciences to $14 From $12, Maintains Hold Rating	MT
04-15	Truist Cuts Price Target on Integra LifeSciences Holdings to $12 From $13, Keeps Hold Rating	MT
01-12	Canaccord Genuity Initiates Coverage on Integra LifeSciences With Speculative Buy Rating, CA$9.25 Price Target	MT
31/07/25	Medtech firm Integra's Q2 revenue beats expectations	RE
13/05/25	Morgan Stanley Adjusts Price Target on Integra LifeSciences Holdings to $10 From $20, Maintains Equalweight Rating	MT
05/05/25	Top Midday Decliners	MT
11/04/25	Truist Cuts Price Target on Integra LifeSciences Holdings to $19 From $26, Keeps Hold Rating	MT
31/03/25	Argus Upgrades Integra LifeSciences to Buy From Hold, Price Target is $28	MT
05/11/24	Truist Raises Price Target on Integra LifeSciences Holdings to $26 From $21, Keeps Hold Rating	MT
14/10/24	Correction: Truist Trims Price Target on Integra LifeSciences Holdings to $21 From $26, Keeps Hold Rating	MT
14/10/24	Truist Raises Price Target on Integra LifeSciences Holdings to $26 From $21, Keeps Hold Rating	MT
07/10/24	BTIG Upgrades Integra LifeSciences Holdings to Neutral From Sell	MT
30/07/24	BTIG Downgrades Integra LifeSciences Holdings to Sell From Neutral, Price Target is $22	MT
30/07/24	Citigroup Downgrades Integra LifeSciences Holdings to Sell From Neutral, Adjusts Price Target to $23 From $30	MT
30/07/24	Analyst recommendations: 3M Company, Aon, Murphy USA, Skyworks, Tesla...
30/07/24	Truist Adjusts Price Target on Integra LifeSciences Holdings to $26 From $32 After 'Big' H2 Guide Cut, Maintains Hold Rating	MT
16/07/24	Truist Raises Price Target on Integra LifeSciences Holdings to $32 From $25, Maintains Hold Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	INTEGRA LIFESCIENCES HOLDINGS CORPORATION					+36.62%
	ABBOTT LABORATORIES					+17.23%
	MEDTRONIC PLC					+10.79%
	STRYKER CORPORATION					+28.76%
	ESSILORLUXOTTICA					+51.22%
	CENCORA, INC.					+10.11%
	HOYA CORPORATION					+18.9%
	BECTON, DICKINSON AND COMPANY					+2.75%
	IDEXX LABORATORIES, INC.					+32.57%
	MEDLINE INC.					+23.64%
	Average					+23.26%
	Weighted average by Cap.					+21.08%